Suppr超能文献

重症监护临床试验的注册和设计变更:一项横断面观察性研究。

Registration and design alterations of clinical trials in critical care: a cross-sectional observational study.

机构信息

Department of Critical Care Medicine, Stollery Children's Hospital, University of Alberta, Edmonton, Canada.

出版信息

Intensive Care Med. 2014 May;40(5):700-22. doi: 10.1007/s00134-014-3250-7. Epub 2014 Apr 16.

Abstract

PURPOSE

In 2005 the International Committee of Medical Journal Editors issued a requirement that all randomized controlled trials (RCTs) be registered primarily to prevent selective reporting (publication bias). However, registries allow for alterations in study protocol. Changes occurring before (or after) study completion could invalidate the original study intent, leading to publication of misleading conclusions. In RCTs involving critically ill patients, these concerns may be particularly acute because mortality is high and conditions investigated are usually syndromes rather than specific diseases. This study was conducted to estimate the registration rate of RCTs in critical care; and, among registered RCTs, to determine timing of registration and whether sample size or primary outcome were altered.

METHODS

We searched the MEDLINE database for RCTs that began after or continued through July 2005. We determined whether each trial had been registered and, for registered trials, compared registry data to data in the published manuscript.

RESULTS

Approximately two-thirds (66%) of trials were registered. Of these, 66% of registrations occurred after enrolment had commenced. Overall, 6% (5/90) of trials appropriately registered a sample size which was unchanged from the interval between registration and publication, and only 12% (11/90) reported primary outcomes that were both appropriately registered and unchanged.

CONCLUSIONS

Non-registration, or registration after trial initiation, are common in RCTs of critically ill patients. Among registered trials important protocol changes are often made between trial commencement and publication. This study identifies and quantifies the extent of this serious-but correctable-problem for RCTs in critically ill patients.

摘要

目的

2005 年,国际医学期刊编辑委员会发布要求,所有随机对照试验(RCT)都需预先注册,主要是为了防止选择性报告(发表偏倚)。然而,注册允许对研究方案进行修改。在研究完成之前(或之后)发生的变化可能会使原始研究意图无效,导致误导性结论的发表。在涉及危重病患者的 RCT 中,这些问题可能尤为突出,因为死亡率高,且研究的病症通常是综合征而不是特定疾病。本研究旨在评估危重病 RCT 的注册率;并在已注册的 RCT 中,确定注册时间以及样本量或主要结局是否发生改变。

方法

我们在 MEDLINE 数据库中搜索了始于 2005 年 7 月之后或持续进行的 RCT。我们确定了每个试验是否已注册,并对已注册的试验,将注册数据与发表的手稿中的数据进行比较。

结果

大约三分之二(66%)的试验已注册。其中,66%的注册发生在入组开始后。总体而言,6%(5/90)的试验适当注册了样本量,与注册和发表之间的时间间隔保持不变,只有 12%(11/90)报告了主要结局,两者都经过适当注册且保持不变。

结论

在危重病患者的 RCT 中,未注册或在试验开始后注册的情况很常见。在已注册的试验中,在试验开始和发表之间经常会进行重要的方案修改。本研究确定并量化了危重病患者 RCT 中这一严重但可纠正的问题的程度。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验